glp-1 sglt2 Inhibitors and Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application For older adults with diabetes,

Dave Asprey : Hi

Results After the intervention in the LC group, plasma total carnitine and serum decorin levels were higher than the corresponding preintervention values (p = 0.040 and p = 0.042, respectively)

Image Credit: zimmytws / Shutterstock In a recent study published in the journal Diabetes, Obesity, and Metabolism , researchers conducted an umbrella review to examine the efficacy and safety of glucagon-like peptide 1 receptor agonists, GLP-1RAs, across all health outcomes in type 2 diabetes, T2D

Borrja-Cacho D, Zwolak P, Yokoyama Y, Ankeny JS, Antonoff MB , Dudeja V, Chugh R, Dawra RK, Vickers SM, Saluja AK